Epidemiology Principles and Methods
Understanding the core concepts of epidemiology is essential for anyone working in general medicine or public health. This course translates the key ideas from a typical quiz into a…

In a case‑control study, which measure of association is most appropriate?
Which bias arises when the control group in a case‑control study is drawn from a hospital population with different exposure patterns?
If a disease is rare, how does the odds ratio compare numerically to the risk ratio?
Which of the following best describes a cohort study’s ability to establish temporality?
In a cross‑sectional survey, which limitation prevents establishing a causal direction?
What does a prevalence of 0.02 indicate in a population of 10 000 individuals?
Which factor is a classic example of a confounder in the relationship between smoking and lung cancer?
When calculating the attributable fraction in the exposed group, which formula is used?
Which study design is most efficient for investigating a rare disease?
What is the main advantage of randomisation in experimental epidemiology?
In a 2 × 2 table, what does a cell count of 'a' represent in the context of diagnostic test evaluation?
If a diagnostic test has a sensitivity of 90 % and specificity of 80 %, what is the likelihood ratio positive (LR+)?
Which of the following best illustrates an ecological fallacy?
What is the primary purpose of a dose‑response relationship in epidemiology?
Which criterion of Hill’s causality framework assesses the strength of association?
In a cohort study, the incidence rate is expressed as:
Which of the following is a correct interpretation of a relative risk (RR) of 2.5?
During a surveillance outbreak, which measure best captures the speed of case accumulation over time?
What is the effect of non‑differential misclassification on the estimated association?
Which of the following best describes the ‘healthy worker effect’ in occupational cohort studies?
In a longitudinal study, what does the term ‘person‑years’ refer to?
Which of the following statements about the attributable risk percent (AR%) in the exposed is true?
When assessing the impact of a preventive factor, which measure quantifies the proportion of cases avoided due to the factor?
Epidemiology Principles and Methods
Understanding the core concepts of epidemiology is essential for anyone working in general medicine or public health. This course translates the key ideas from a typical quiz into a comprehensive, SEO‑friendly lesson that covers descriptive epidemiology, study designs, measures of association, bias, and common calculations.
1. Descriptive Epidemiology: The Starting Point
Primary objective: To study the frequency and distribution of health problems in populations. Descriptive epidemiology answers the classic "who, what, when, and where" questions.
- Who: Demographic characteristics such as age, sex, ethnicity.
- What: Type of disease or health event.
- When: Temporal trends, seasonality, or outbreak timing.
- Where: Geographic location, setting (urban vs. rural), or specific institutions.
By mapping these elements, public health professionals can generate hypotheses, allocate resources, and design targeted interventions.
2. Study Designs and Their Measures of Association
2.1 Case‑Control Studies
Case‑control studies start with groups defined by outcome (cases) and compare them to a control group without the outcome. Because the total number of people at risk is not known, the odds ratio (OR) is the natural measure of association.
Why odds ratio? The OR compares the odds of exposure among cases to the odds of exposure among controls, providing a ratio that approximates the risk ratio when the disease is rare.
- Formula:
OR = (a/c) / (b/d) = (a·d) / (b·c) - Interpretation: OR > 1 suggests a positive association; OR < 1 suggests a protective effect.
2.2 Cohort Studies
Cohort studies follow a group of exposed and unexposed individuals over time to observe the incidence of disease. The design ensures that exposure precedes outcome, establishing temporality—a crucial criterion for causal inference.
- Common measures: Risk ratio (relative risk) and incidence rate.
- Temporality advantage: Because participants are observed prospectively, the direction of cause and effect is clear.
2.3 Cross‑Sectional Surveys
Cross‑sectional surveys assess exposure and disease status simultaneously. While useful for estimating prevalence, they cannot determine causal direction because the timing of exposure relative to outcome is unknown.
- Key limitation: Simultaneous measurement of exposure and disease prevents establishing temporality.
- Typical use: Snapshot of disease burden, identification of risk factors for further study.
3. Understanding Bias in Epidemiologic Research
3.1 Selection Bias
Selection bias occurs when the method of selecting participants leads to a systematic difference between those included in the study and the target population. In case‑control studies, drawing controls from a hospital population with different exposure patterns than the source population can introduce selection bias.
3.2 Information Bias
Information bias arises from misclassification of exposure or outcome, often due to inaccurate measurement tools or recall errors. While not the focus of the quiz, it is important to differentiate it from selection bias.
3.3 Confounding
A confounder is a third variable that is associated with both the exposure and the outcome, potentially distorting the true association. A classic example in the smoking‑lung cancer relationship is age, because older individuals are more likely to have smoked longer and also have a higher baseline risk of lung cancer.
4. Measures of Association: Odds Ratio vs. Risk Ratio
When a disease is rare, the odds ratio approximates the risk ratio. This occurs because the odds of disease are close to the probability (risk) when the event rate is low. Therefore, for rare outcomes, OR ≈ RR, making the odds ratio a practical estimate even when the true risk ratio cannot be directly calculated.
5. Prevalence Calculations and Interpretation
Prevalence is the proportion of a population that has a disease at a specific point in time. It is calculated as:
Prevalence = (Number of existing cases) / (Total population)
For a prevalence of 0.02 in a population of 10,000, the calculation is:
0.02 × 10,000 = 200 existing cases
This figure represents the total number of individuals who have the disease at the moment of measurement, not new cases or deaths.
6. Practical Application: Interpreting Quiz Questions
- Descriptive epidemiology focuses on frequency and distribution, not on testing causality.
- In a case‑control study, the odds ratio is the appropriate measure of association.
- Choosing controls from a hospital with different exposure patterns introduces selection bias.
- For rare diseases, the odds ratio and risk ratio are approximately equal.
- A cohort design guarantees that exposure precedes outcome, satisfying temporality.
- Cross‑sectional surveys cannot establish causality because exposure and outcome are measured at the same time.
- A prevalence of 0.02 in a 10,000‑person population corresponds to 200 existing cases.
- Age is a classic confounder in the smoking‑lung cancer relationship.
7. Key Take‑aways for Medical and Public Health Professionals
Mastering epidemiologic principles equips clinicians and public health workers to critically evaluate research, design robust studies, and implement evidence‑based interventions. Remember these core points:
- Descriptive epidemiology sets the stage for hypothesis generation.
- Choose the correct measure of association based on study design.
- Identify and mitigate bias—especially selection bias in case‑control studies.
- Recognize when odds ratios can approximate risk ratios.
- Understand the limitations of cross‑sectional data for causal inference.
- Calculate and interpret prevalence accurately.
- Always assess potential confounders, such as age, that may distort observed relationships.
By integrating these concepts, you will be better prepared to design, analyze, and interpret epidemiologic research, ultimately improving health outcomes at both the individual and population levels.
